The article discusses the poor performance of Biogen Inc. (NASDAQ:BIIB) in 2024 compared to other NASDAQ stocks. Factors impacting stock market momentum include AI, earnings, interest rates, and geopolitical tensions. Despite setbacks, Biogen aims to cut costs and introduce new products.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing